lapatinib has been researched along with diflunisal in 2 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (diflunisal) | Trials (diflunisal) | Recent Studies (post-2010) (diflunisal) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 605 | 129 | 145 |
| Protein | Taxonomy | lapatinib (IC50) | diflunisal (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 3.38 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 2.7 | |
| Transthyretin | Homo sapiens (human) | 5.4667 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 0.85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for lapatinib and diflunisal
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for lapatinib and diflunisal
| Article | Year |
|---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |